OSTARINA (MK-2866) · 20 MG · 60 TABLETAS | Modulador Selectivo. Rendimiento Avanzado.

Ostarine (MK-2866) 20 mg tablets, from Kinetix Pharma, made in the Czech Republic. Each package contains 60 tablets of 20 mg each. This is a pharmaceutical-grade non-steroidal selective androgen receptor modulator (SARM) intended for human use. The active ingredient is ostarine (enobosarm), which promotes preservation and gain of lean muscle mass with unprecedented tissue selectivity. Used for muscle mass preservation during cutting and body recomposition cycles. CAS: 841205-47-8. Molecular formula: C₁₉H₁₄F₃N₃O₃. Store at room temperature in a dry place protected from light. WARNING: This product is an investigational compound and its use must be supervised by a physician. Banned by WADA. May cause hormonal axis suppression, transaminase elevation, and adverse effects on lipid profile.

Ostarine (MK-2866), also known as Enobosarm, is a next-generation non-steroidal selective androgen receptor modulator (SARM). Designed to mimic the anabolic action of testosterone in muscle and bone tissue, it promotes muscle growth and strength with unprecedented tissue selectivity. In the sports performance and research field, it is primarily used to preserve muscle mass during cutting phases or to promote lean tissue gains, maintaining high activity in muscle and bone.

The problem it solves: During intense training cycles or caloric restriction phases, athletes may experience muscle tissue loss. Ostarine, unlike traditional anabolic steroids, was developed to be selective with minimal impact on organs such as the prostate. Its targeted action profile makes it an advanced research tool for those seeking a more specific and potentially more favorable side effect profile.

Primary Benefit: Preservation and Gain of Lean Muscle Mass

At its core, Ostarine is designed to activate the androgen receptor (AR) with high affinity (Ki of 3.8 nM), activating pathways that promote protein synthesis in muscle. Its selective action seeks an anabolic effect in muscle and bone tissue, with less impact on tissues such as the prostate compared to testosterone. Recent clinical evidence demonstrates that Ostarine significantly preserves lean muscle mass, even in the context of GLP-1 drug-induced weight loss.

Secondary Benefits: Definition, Performance, and Recovery

Ostarine's action on the androgen receptor offers additional benefits:

Greater Muscle Definition: Ostarine does not aromatize to estrogen and does not cause the subcutaneous fluid retention typical of steroids, resulting in a drier, harder, and more vascular physique. Any weight gain is predominantly lean mass and intramuscular water (inside the muscle cell), not subcutaneous or extracellular bloating.

Enhanced Recovery: Users report noticeable improvements in recovery between training sessions, with increased muscle fullness and vascularity beginning to appear in week 2-3.

Osteoanabolic Effect: Ostarine has a positive effect on bone tissue, promoting bone formation and helping maintain bone mineral density, contributing to overall musculoskeletal health.

Pairing Strategy: Ostarine

Ostarine is typically used as a standalone agent for body recomposition or in cutting cycles. Cycling protocols vary according to goals: 8 weeks for an initial recomposition cycle (10-15 mg), 8-10 weeks for a classic cut (20-25 mg). Its use without an adequate post-cycle therapy (PCT) protocol is not recommended, especially at doses above 15 mg/day or cycles longer than 8 weeks.